Globeflex Capital L P purchased a new stake in Genpact Limited (NYSE:G - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 131,887 shares of the business services provider's stock, valued at approximately $3,627,000. Globeflex Capital L P owned approximately 0.08% of Genpact as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in G. Qsemble Capital Management LP purchased a new position in shares of Genpact during the fourth quarter valued at $3,258,000. Universal Beteiligungs und Servicegesellschaft mbH raised its position in Genpact by 30.6% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 145,336 shares of the business services provider's stock valued at $6,810,000 after buying an additional 34,039 shares during the period. Arbejdsmarkedets Tillaegspension purchased a new stake in Genpact in the 4th quarter worth about $23,777,000. LSV Asset Management lifted its stake in Genpact by 15.1% in the 4th quarter. LSV Asset Management now owns 2,467,612 shares of the business services provider's stock worth $115,435,000 after acquiring an additional 324,345 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Genpact by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 4,330,116 shares of the business services provider's stock worth $210,391,000 after acquiring an additional 107,870 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Stock Performance
G stock opened at $37.16 on Monday. The firm has a 50 day moving average of $31.68 and a two-hundred day moving average of $34.42. Genpact Limited has a 12 month low of $26.85 and a 12 month high of $48.64. The company has a market capitalization of $6.24 billion, a price-to-earnings ratio of 11.03, a P/E/G ratio of 0.99 and a beta of 0.57. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.44.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Tuesday, June 30th. The business services provider reported $1.00 earnings per share for the quarter. Genpact had a net margin of 11.04% and a return on equity of 23.34%. The business had revenue of $1.34 billion for the quarter. As a group, equities analysts anticipate that Genpact Limited will post 3.67 EPS for the current fiscal year.
Genpact Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, September 10th will be issued a dividend of $0.1875 per share. This represents a $0.75 annualized dividend and a yield of 2.0%. The ex-dividend date is Thursday, September 10th. Genpact's dividend payout ratio (DPR) is 22.26%.
Insiders Place Their Bets
In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the business's stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total value of $229,252.73. Following the completion of the sale, the senior vice president owned 70,253 shares of the company's stock, valued at $2,601,468.59. The trade was a 8.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.58% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on G. TD Cowen upped their target price on Genpact from $42.00 to $43.00 and gave the company a "buy" rating in a report on Friday, August 7th. Needham & Company LLC decreased their price target on shares of Genpact from $50.00 to $45.00 and set a "buy" rating for the company in a report on Friday, August 7th. Weiss Ratings lowered shares of Genpact from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday, June 24th. BMO Capital Markets reiterated a "market perform" rating and issued a $40.00 target price on shares of Genpact in a research report on Friday, August 7th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Genpact from $40.00 to $45.00 and gave the company a "neutral" rating in a report on Friday, August 7th. Two research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $39.33.
Read Our Latest Analysis on Genpact
Genpact Company Profile
(
Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Further Reading
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
